Marson T. The SANAD II study of effectiveness of valproate or levetiracetam in generalised and unclassifiable epilepsy: an un-blinded randomised controlled trial. 5th European Academy of Neurology (EAN) Congress, abstract O4125.
Biomarkers kunnen 'Lewy body'-dementie van Alzheimer onderscheiden
okt 2023 | Dementie